
Between February 1984 and September 1990, 60 patients with zzso zzso were treated with zzso zzso in the Department of zzso Oncology at the University of California, San zzso zzso children zzso or zzso 18 zzso and 19 adults were treated with 100 zzso twice daily with zzso zzso between zzso Thirty-one patients (21 children and 10 zzso received total doses of zzso zzso and 29 patients (20 children and nine zzso received zzso zzso Median follow-up was 208 weeks for all patients zzso weeks for children, 157 weeks for zzso zzso patients zzso children and nine zzso were alive at the time of analysis, surviving zzso weeks following zzso Median zzso survival was zzso weeks overall zzso weeks for children, 190 weeks for adults; p zzso zzso Survival at 12 and 24 months was zzso and zzso respectively zzso and zzso for children; zzso and zzso for zzso All patients had zzso magnetic resonance imaging by which tumors were classified as either focal or zzso No significant zzso zzso factors for adults were zzso In children, significant favorable zzso factors on zzso analysis were older age zzso zzso zzso tumor location in zzso or zzso zzso zzso zzso focal appearance on zzso scan zzso zzso zzso and duration of symptoms zzso 2 months prior to treatment zzso zzso zzso Thirty-five patients had tumor zzso leading to a diagnosis in 33 zzso children and 11 zzso Children with moderately zzso zzso survived significantly longer than those with zzso zzso or zzso tumors zzso zzso zzso Only duration of symptoms zzso 2 months remained significant as a favorable zzso indicator for children on zzso analysis zzso zzso zzso Survival was not significantly different for patients receiving zzso or zzso 72 zzso and those receiving zzso 72 zzso zzso zzso zzso No zzso of patients showed significantly better survival with the higher zzso These findings indicate that zzso zzso is effective treatment for adults and a zzso of better prognosis children with zzso zzso There is a zzso of pediatric patients with extremely poor prognosis for whom even this aggressive treatment does little to extend zzso We conclude that there is no benefit to increasing total dose above 72 zzso for any of the groups zzso 

